Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 USD | -1.98% | -10.26% | -72.96% |
May. 15 | Windtree Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 17 | Windtree Therapeutics Seeks Acquisitions | CI |
Business Summary
Number of employees: 20
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 14-05-19 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 13-10-31 |
Diane Carman
LAW | General Counsel | 55 | 21-06-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 591,909 | 568,154 ( 95.99 %) | 0 ( 0.000009 %) | 95.99 % |
Company contact information
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-72.96% | 1.78M | |
+45.24% | 56.65B | |
-6.86% | 39.44B | |
+39.33% | 39.03B | |
-11.17% | 26.86B | |
+13.46% | 26.75B | |
-21.31% | 19.03B | |
+0.31% | 12.28B | |
+26.08% | 12.26B | |
+27.44% | 12.04B |
- Stock Market
- Equities
- WINT Stock
- Company Windtree Therapeutics, Inc.